Description

NURECA LIMITED has fixed December 12, 2025 as the record date for determining shareholders eligible to participate in the buyback offer.

Summary

NURECA LIMITED (Scrip Code: 543264) has announced a buyback of equity shares through a tender offer. The company has fixed December 12, 2025 as the record date to determine the entitlement and names of equity shareholders eligible to participate in the buyback offer. The ex-entitlement date is also December 12, 2025, with settlement number DR-776/2025-2026.

Key Points

  • Company: NURECA LIMITED (Scrip Code: 543264)
  • Record Date: December 12, 2025
  • Ex-Entitlement Date: December 12, 2025
  • Settlement Number: DR-776/2025-2026
  • Purpose: Determine shareholders eligible for buyback participation
  • Segment: Dematerialised Securities – Rolling Settlement
  • Notice Number: 20251210-13

Regulatory Changes

No regulatory changes are introduced in this circular. This is a standard corporate action announcement for a buyback offer.

Compliance Requirements

  • Trading members of BSE must take note of the record date and ex-entitlement date
  • Only shareholders holding shares as of the record date (December 12, 2025) will be eligible to participate in the buyback
  • Shares will trade on ex-entitlement basis from December 12, 2025

Important Dates

  • Notice Date: December 10, 2025
  • Record Date: December 12, 2025
  • Ex-Entitlement Date: December 12, 2025
  • Settlement Number: DR-776/2025-2026

Impact Assessment

Market Impact: Medium - This buyback announcement affects NURECA LIMITED shareholders specifically. Shareholders on record as of December 12, 2025 will have the opportunity to tender their shares in the buyback offer.

Operational Impact: Trading members need to ensure proper tracking of the ex-entitlement date to correctly identify eligible shareholders. The buyback may result in:

  • Potential share price support
  • Reduction in outstanding share capital
  • Exit opportunity for shareholders
  • Possible impact on liquidity during the tender offer period

Investor Impact: Shareholders holding shares before the ex-date will be eligible to participate in the buyback, potentially providing an exit route at the offer price.

Impact Justification

Company-specific buyback event affecting NURECA shareholders. Medium impact as it provides exit opportunity for shareholders who wish to participate in the tender offer.